Related Experiment Video
Updated: Jun 28, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem Cell Therapy against Ischemic Heart Disease
I-Ting Tsai1,2, Cheuk-Kwan Sun2,3
1Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung City 82445, Taiwan.
Insights
Stem cell therapy shows promise for treating ischemic heart disease by promoting heart repair and function. This review examines experimental and clinical outcomes of stem cells and exosomes in managing this leading cause of death.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Ischemic heart disease (IHD) is a major global health burden, leading to myocardial infarction and heart failure.
- Cardiomyocytes have limited regenerative capacity, contributing to disease progression despite medical advancements.
- Ischemia-reperfusion injury and oxidative stress further impair cardiac function post-myocardial infarction.
Purpose of the Study:
- To review the therapeutic applications of stem cells in various forms of ischemic heart disease.
- To summarize experimental and clinical findings on stem cell-based therapies for IHD.
- To explore the proposed mechanisms of action for stem cells and exosomes in cardiac repair.
Main Methods:
- Review of experimental and clinical studies on stem cell therapy for ischemic heart disease.
- Analysis of data concerning different stem cell types (mesenchymal stem cells, progenitor cells, iPSCs) and exosomes.
- Examination of proposed therapeutic mechanisms, including paracrine effects.
Main Results:
- Various stem cell types demonstrate therapeutic potential in preclinical and clinical studies of IHD.
- Stem cell-derived exosomes are emerging as a significant therapeutic avenue.
- Paracrine signaling plays a crucial role in the observed benefits of stem cell therapies.
Conclusions:
- Stem cell therapy, including the use of exosomes, offers a promising strategy for treating ischemic heart disease.
- Further research is needed to validate findings and address potential issues like data integrity.
- Understanding stem cell mechanisms is key to optimizing regenerative therapies for cardiac repair.
Abstract:
Ischemic heart disease, which is one of the top killers worldwide, encompasses a series of heart problems stemming from a compromised coronary blood supply to the myocardium. The severity of the disease ranges from an unstable manifestation of ischemic symptoms, such as unstable angina, to myocardial death, that is, the immediate life-threatening condition of myocardial infarction. Even though patients may survive myocardial infarction, the resulting ischemia-reperfusion injury triggers a cascade of inflammatory reactions and oxidative stress that poses a significant threat to myocardial function following successful revascularization. Moreover, despite evidence suggesting the presence of cardiac stem cells, the fact that cardiomyocytes are terminally differentiated and cannot significantly regenerate after injury accounts for the subsequent progression to ischemic cardiomyopathy and ischemic heart failure, despite the current advancements in cardiac medicine. In the last two decades, researchers have realized the possibility of utilizing stem cell plasticity for therapeutic purposes. Indeed, stem cells of different origin, such as bone-marrow- and adipose-derived mesenchymal stem cells, circulation-derived progenitor cells, and induced pluripotent stem cells, have all been shown to play therapeutic roles in ischemic heart disease. In addition, the discovery of stem-cell-associated paracrine effects has triggered intense investigations into the actions of exosomes. Notwithstanding the seemingly promising outcomes from both experimental and clinical studies regarding the therapeutic use of stem cells against ischemic heart disease, positive results from fraud or false data interpretation need to be taken into consideration. The current review is aimed at overviewing the therapeutic application of stem cells in different categories of ischemic heart disease, including relevant experimental and clinical outcomes, as well as the proposed mechanisms underpinning such observations.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
iPS Cell Differentiation

